Lundbeckfond Invest A/S

Insider Reports History

Location
Scherfigsvej 7, Copenhagen, Denmark
Signature
/s/ Christian E. Elling, Managing Partner and /s/ Lene Skole, Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lundbeckfond Invest A/S:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. 10%+ Owner Common Stock 1.84M $20.2M $11.00 Nov 7, 2023 Direct
IO Biotech, Inc. Director, 10%+ Owner Common Stock 14M $14.4M $1.04 Aug 9, 2023 Direct
IO Biotech, Inc. Director, 10%+ Owner Warrants (Right to Buy) 7.9M Aug 9, 2023 Direct
Lexeo Therapeutics, Inc. 10%+ Owner Series A convertible preferred stock 0 Nov 7, 2023 Direct
Lexeo Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 Nov 7, 2023 Direct

Insider Reports Filed by Lundbeckfond Invest A/S

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXEO Lexeo Therapeutics, Inc. Nov 7, 2023 5 $2.5M 4 Nov 9, 2023 10%+ Owner
LXEO Lexeo Therapeutics, Inc. Nov 2, 2023 0 $0 3 Nov 2, 2023 10%+ Owner
IOBT IO Biotech, Inc. Aug 9, 2023 2 $16M 4 Aug 11, 2023 Director, 10%+ Owner
IOBT IO Biotech, Inc. Nov 9, 2021 5 $30M 4 Nov 12, 2021 10%+ Owner
IOBT IO Biotech, Inc. Nov 4, 2021 0 $0 3 Nov 4, 2021 10%+ Owner